Literature DB >> 23580149

"Idiopathic Bence-Jones proteinuria": a new characterization of an old entity.

Michael Mian1, Irene Franz, Ines Wasle, Manfred Herold, Andrea Griesmacher, Wolfgang Prokop, Sergio Cortelazzo, Günther Gastl, Wolfgang Willenbacher, Eberhard Gunsilius, Michael Fiegl.   

Abstract

Idiopathic Bence-Jones proteinuria (BJP) is a rare plasma cell dyscrasia, of which the clinical and biological characteristics are yet unclear. Historical data suggested that they are at higher risk of progression to multiple myeloma or other related neoplasms, while recent findings are contradictory. To address these open questions, we evaluated a series of both BJP and monoclonal gammopathy of undetermined significance (MGUS) with production of an intact immunoglobulin plus Bence-Jones proteinuria (MGUS+BJP) with long-term follow-up, regarding their clinical characteristics and progression to multiple myeloma, amyloidosis or other related B cell lymphoproliferative disorders. Two hundred and twenty-nine persons fulfilling the 2004 criteria of MGUS were included in the final analyses: 31 had BJP and 198 had MGUS+BJP. At the time of diagnosis, significantly more persons in the BJP group had renal impairment, anaemia and polyneuropathy. A more detailed analysis revealed discrepancies between the serum and urine light chain type in nine cases, reflecting clonal heterogeneity. The number of disease progressions was higher in MGUS+BJP (n = 30) when compared to BJP (n = 1), with a rate of 1.6 and 0.4 progressions per 100 person-years, respectively. In conclusion, BJP has distinct clinical characteristics and a lower risk of progression when compared to MGUS+BJP. Our data suggest that MGUS+BJP being closer to malignant transformation may be due to the higher portion of genetically heterogeneous, pre-malignant plasma cell subclones.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23580149     DOI: 10.1007/s00277-013-1739-8

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  2 in total

Review 1.  The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network.

Authors:  Niels W C J van de Donk; Antonio Palumbo; Hans Erik Johnsen; Monika Engelhardt; Francesca Gay; Henrik Gregersen; Roman Hajek; Martina Kleber; Heinz Ludwig; Gareth Morgan; Pellegrino Musto; Torben Plesner; Orhan Sezer; Evangelos Terpos; Anders Waage; Sonja Zweegman; Hermann Einsele; Pieter Sonneveld; Henk M Lokhorst
Journal:  Haematologica       Date:  2014-03-21       Impact factor: 9.941

2.  Monoclonal gammopathy of renal significance: systemic involvement by benign condition.

Authors:  Vincenzo L'Imperio; Paolo Fabbrini; Franco Ferrario; Federico Pieruzzi; Antonella Tosoni; Rinaldo Brivio; Enrico Maria Pogliani; Fabio Pagni
Journal:  Kidney Int       Date:  2015-07       Impact factor: 10.612

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.